Anti-pBM8 T cell receptor (BM3.3), pCDTCR1(TCR-C209Z)
The vector of anti-pBM8 T cell receptor (TCR) is constructed for the engineering of T cell to target Mouse pBM8. The T cells are genetically modified through transduction with a lentiviral vector expressing pBM8-specific T cell receptor.
RNA-binding protein 5
RBM5; RNA-binding protein 5
Component of the spliceosome A complex. Regulates alternative splicing of a number of mRNAs. May modulate splice site pairing after recruitment of the U1 and U2 snRNPs to the 5' and 3' splice sites of the intron. May both positively and negatively regulate apoptosis by regulating the alternative splicing of several genes involved in this process, including FAS and CASP2/caspase-2. In the case of FAS, promotes production of a soluble form of FAS that inhibits apoptosis. In the case of CASP2/caspase-2, promotes production of a catalytically active form of CASP2/Caspase-2 that induces apoptosis.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.